Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
Abstract Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by marked accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid (BALF). Patients with CEP usually respond well to corticosteroids. However, more than half of these patients relapse while tapering...
Main Authors: | Tomotsugu Takano, Yuh Inutsuka, Satoshi Nakamura, Nobuhisa Ando, Masashi Komori |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Respirology Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/rcr2.810 |
Similar Items
-
Successful treatment of eosinophilic cystitis with benralizumab
by: W Donald Cooke, et al.
Published: (2020-11-01) -
Successful discontinuation of corticosteroids through remission induction therapy with benralizumab for chronic eosinophilic pneumonia
by: Yoshiro Kai, et al.
Published: (2024-01-01) -
Successful Introduction of Benralizumab for Eosinophilic Ascites
by: Nabil Belfeki, et al.
Published: (2024-01-01) -
A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
by: Daiki Nakashima, et al.
Published: (2024-01-01) -
Treatment of Widespread Eosinophilic Cellulitis (Wells’ Syndrome) with Benralizumab
by: Maria Blomberg, et al.
Published: (2020-11-01)